These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 19853481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
    Roberts LM, Davies JS, Sempowski GD, Frelinger JA.
    Vaccine; 2014 Jun 17; 32(29):3595-603. PubMed ID: 24837506
    [Abstract] [Full Text] [Related]

  • 4. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL.
    J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination.
    Gopal R, Lin Y, Obermajer N, Slight S, Nuthalapati N, Ahmed M, Kalinski P, Khader SA.
    Eur J Immunol; 2012 Feb 15; 42(2):364-73. PubMed ID: 22101830
    [Abstract] [Full Text] [Related]

  • 7. Th17 cytokines in recall responses against Francisella tularensis in humans.
    Paranavitana C, Zelazowska E, DaSilva L, Pittman PR, Nikolich M.
    J Interferon Cytokine Res; 2010 Jul 15; 30(7):471-6. PubMed ID: 20626289
    [Abstract] [Full Text] [Related]

  • 8. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
    Karttunen R, Surcel HM, Andersson G, Ekre HP, Herva E.
    J Clin Microbiol; 1991 Apr 15; 29(4):753-6. PubMed ID: 1909711
    [Abstract] [Full Text] [Related]

  • 9. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD, Singh R, Metzger DW.
    Infect Immun; 2007 May 15; 75(5):2152-62. PubMed ID: 17296747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S.
    Microbiol Immunol; 2018 Jan 15; 62(1):24-33. PubMed ID: 29171073
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar 15; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 17. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA, Raulie EK, Lauriano CM, Klose KE, Arulanandam BP.
    Infect Immun; 2006 Apr 15; 74(4):2063-71. PubMed ID: 16552035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W.
    Infect Immun; 2007 Apr 15; 75(4):1651-60. PubMed ID: 17242058
    [Abstract] [Full Text] [Related]

  • 20. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P, Anipindi VC, Nguyen PV, Vitali D, Stämpfli MR, Kaushic C.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28956763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.